SCM
TYRA icon

Sterling Capital Management’s Tyra Biosciences TYRA Stock Holding History

Sterling Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.9K Sell
858
-630
-42% -$20.4K ﹤0.01% 1809
2025
Q4 		$39.1K Sell
1,488
-174
-10% -$3.2K ﹤0.01% 1896
2025
Q3 		$23.3K Buy
1,662
+1,012
+156% +$11.5K ﹤0.01% 2077
2025
Q2 		$6.22K Buy
650
+629
+2,995% +$5.98K ﹤0.01% 2398
2025
Q1 		$195 Hold
21
– – ﹤0.01% 3087
2024
Q4 		$292 Hold
21
– – ﹤0.01% 3083
2024
Q3 		$494 Buy
+21
New +$441 ﹤0.01% 2876

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Sterling Capital Management's TYRA Position: Q1 2026 in Review

Sterling Capital Management reduced its Tyra Biosciences (TYRA) stake by 42% in Q1 2026, selling an estimated $20.4K and leaving 858 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

Sterling Capital Management first reported a position in TYRA in Q3 2024 and has held it in 7 quarters since. The position peaked at $39.1K in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Sterling Capital Management held 858 shares of Tyra Biosciences worth $32.9K as of Q1 2026.
  • Sterling Capital Management sold 630 Tyra Biosciences shares in Q1 2026, an estimated $20.4K.
  • Tyra Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #1809 holding.
  • Sterling Capital Management first reported a position in Tyra Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Tyra Biosciences position peaked at $39.1K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.